Cargando…
Sorafenib and locoregional deep electro-hyperthermia in advanced hepatocellular carcinoma: A phase II study
The standard treatment for advanced hepatocellular carcinoma (HCC) is sorafenib, a multikinase inhibitor of tumor cell proliferation and angiogenesis. Hyperthermia inhibits angiogenesis and promotes apoptosis. Potential synergic antiangiogenic and proapoptotic effects represent the rationale for com...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4156230/ https://www.ncbi.nlm.nih.gov/pubmed/25202410 http://dx.doi.org/10.3892/ol.2014.2376 |